# Pluvicto Real-world Investigation in Survival in Metastatic CRPC

> clinical trial · VERIFIED · 2026-07-13

Status: NOT_YET_RECRUITING · Sponsor: Novartis Pharmaceuticals · Condition: Prostatic Neoplasms, Castration-Resistant

- Company: Novartis Pharmaceuticals
- Sector: Prostatic Neoplasms, Castration-Resistant
- Primary source: https://clinicaltrials.gov/study/NCT07697989

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.